Peptides and their potential role in the treatment of diabetes and obesity.
about
Nutritional Signaling via Free Fatty Acid ReceptorsDietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulationChallenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies.The Neuropeptide 26RFa (QRFP) and Its Role in the Regulation of Energy Homeostasis: A Mini-ReviewPosition and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa ratsRegulation of Appetite, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP)Small lipidated anti-obesity compounds derived from neuromedin U.The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue.The SCFA Receptor GPR43 and Energy Metabolism.Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity.Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity: the case for personalized combinatorial therapies.Gut microbial metabolite short-chain fatty acids and obesityHigh molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice.Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice.
P2860
Q26749828-0F34E741-3E98-4A1B-89DA-E8EA2EE4C5F3Q27022777-6F44FA33-F196-4E6E-B69B-6F6BAA025C39Q27331844-0BB306C2-F7D9-4D9B-B8DF-EA684EED7485Q28068059-66907CD2-00E0-4635-94F4-CF1F4826636FQ33919544-C0BF608B-82C3-4E72-87B5-A9F1F6820A2CQ34344972-0DB9D1A2-DA5B-4E4C-89D0-217B59D79933Q35691135-06F2ADA8-51E9-47BE-AC98-3D696F7F69F0Q35708420-8CCF2D49-9247-4F4B-BC78-5DD5E9142C98Q35760275-2345AC08-DF71-4881-A8BC-CBA0475FB6DEQ38219970-532AB735-03A9-49BD-8E07-D5256B918373Q38820528-FE536991-DC11-4CEB-8ECF-1CF99B78F34DQ41884876-56F7BFE2-BEA7-4BF9-A50F-B14AE7FC2E15Q42373289-71D79967-659D-44B5-9E1A-5D940286E2AFQ42709946-B36BF231-4983-43ED-91DA-EC3018953283Q55008471-B1170763-A1FC-461A-B213-F76A12A08281
P2860
Peptides and their potential role in the treatment of diabetes and obesity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Peptides and their potential role in the treatment of diabetes and obesity.
@ast
Peptides and their potential role in the treatment of diabetes and obesity.
@en
type
label
Peptides and their potential role in the treatment of diabetes and obesity.
@ast
Peptides and their potential role in the treatment of diabetes and obesity.
@en
prefLabel
Peptides and their potential role in the treatment of diabetes and obesity.
@ast
Peptides and their potential role in the treatment of diabetes and obesity.
@en
P2860
P356
P1476
Peptides and their potential role in the treatment of diabetes and obesity.
@en
P2093
Hannah C Greenwood
Stephen R Bloom
P2860
P304
P356
10.1900/RDS.2011.8.355
P577
2011-11-10T00:00:00Z